| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF823 ZNF274 ZNF473 ZNF174 PEG3 NSD1 ZNF213 ZNF226 REST CREBBP ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 PREB ZNF708 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF66 NFXL1 ZNF737 NLRC5 ZNF30 ZNF705B MGA PRDM14 EP300 | 8.13e-12 | 1459 | 111 | 32 | GO:0000977 |
| GeneOntologyMolecularFunction | zinc ion binding | ADAMTS1 ENPP1 DBF4B UBR4 NSD1 ZMYM2 TUT1 ADAMTS8 CREBBP CRIP1 USP20 ZBBX PARP1 RNF2 ADAMTS9 LNPEP TRIM17 NFXL1 TNKS ALB EP300 USP33 | 3.29e-09 | 891 | 111 | 22 | GO:0008270 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF823 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 ZNF226 REST ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF66 NFXL1 ZNF737 ZNF30 ZNF705B MGA NOTCH1 | 1.00e-08 | 1412 | 111 | 27 | GO:0000981 |
| GeneOntologyMolecularFunction | transition metal ion binding | ADAMTS1 ENPP1 DBF4B UBR4 NSD1 ZMYM2 TUT1 ADAMTS8 CREBBP CRIP1 USP20 ZBBX PARP1 RNF2 ADAMTS9 LNPEP TRIM17 NFXL1 TNKS ALB EP300 USP33 | 5.33e-07 | 1189 | 111 | 22 | GO:0046914 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF274 ZNF473 ZNF174 NSD1 ZNF213 ZNF226 REST PREB ZNF708 ZNF605 SALL1 ZNF334 GLI1 ZNF197 ZNF66 ZNF737 NLRC5 ZNF30 MGA EP300 NOTCH1 | 6.02e-06 | 1271 | 111 | 21 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF274 ZNF473 ZNF174 NSD1 ZNF213 ZNF226 REST PREB ZNF708 ZNF605 SALL1 ZNF334 GLI1 ZNF197 ZNF66 ZNF737 NLRC5 ZNF30 MGA EP300 | 1.55e-05 | 1244 | 111 | 20 | GO:0000978 |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 3.06e-05 | 2 | 111 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 3.06e-05 | 2 | 111 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 5.63e-05 | 120 | 111 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | chromatin binding | ZNF274 NSD1 REST CREBBP MSL2 RING1 PARP1 SALL1 RNF2 GLI1 PRDM14 EP300 NOTCH1 BAHCC1 | 6.07e-05 | 739 | 111 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 9.15e-05 | 3 | 111 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.28e-04 | 200 | 111 | 7 | GO:0008237 | |
| GeneOntologyMolecularFunction | dinucleotide phosphatase activity | 1.07e-03 | 9 | 111 | 2 | GO:0004551 | |
| GeneOntologyMolecularFunction | transcription regulator activator activity | 1.34e-03 | 10 | 111 | 2 | GO:0140537 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.18e-07 | 3 | 26 | 3 | HP:0005895 | |
| HumanPheno | Plantar crease between first and second toes | 2.51e-05 | 2 | 26 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.51e-05 | 2 | 26 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.51e-05 | 2 | 26 | 2 | HP:0001042 | |
| HumanPheno | Urethral valve | 2.52e-05 | 12 | 26 | 3 | HP:0010481 | |
| HumanPheno | Hydrocele testis | 2.81e-05 | 36 | 26 | 4 | HP:0000034 | |
| HumanPheno | Laryngeal cartilage malformation | 7.49e-05 | 3 | 26 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 7.49e-05 | 3 | 26 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 7.49e-05 | 3 | 26 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 7.49e-05 | 3 | 26 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 7.49e-05 | 3 | 26 | 2 | HP:0005322 | |
| HumanPheno | Vesicoureteral reflux | 8.54e-05 | 221 | 26 | 7 | HP:0000076 | |
| HumanPheno | Trichiasis | 1.49e-04 | 4 | 26 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.49e-04 | 4 | 26 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.49e-04 | 4 | 26 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.49e-04 | 4 | 26 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.49e-04 | 4 | 26 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.49e-04 | 4 | 26 | 2 | HP:0031207 | |
| HumanPheno | Abnormal ureter physiology | 1.64e-04 | 245 | 26 | 7 | HP:0025634 | |
| HumanPheno | Brachydactyly (hand) | 1.70e-04 | 430 | 26 | 9 | HP:0100667 | |
| HumanPheno | Agenesis of permanent teeth | 1.95e-04 | 23 | 26 | 3 | HP:0006349 | |
| HumanPheno | Broad hallux phalanx | 2.23e-04 | 24 | 26 | 3 | HP:0010059 | |
| HumanPheno | Aortic valve stenosis | 2.23e-04 | 113 | 26 | 5 | HP:0001650 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 2.39e-04 | 350 | 26 | 8 | HP:0006705 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 2.48e-04 | 5 | 26 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 2.48e-04 | 5 | 26 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 2.48e-04 | 5 | 26 | 2 | HP:0030421 | |
| HumanPheno | Abnormality of the urethra | 3.09e-04 | 465 | 26 | 9 | HP:0000795 | |
| HumanPheno | Abnormal heart valve morphology | 3.68e-04 | 588 | 26 | 10 | HP:0001654 | |
| HumanPheno | Urethral obstruction | 3.68e-04 | 69 | 26 | 4 | HP:0000796 | |
| HumanPheno | Large foramen magnum | 3.71e-04 | 6 | 26 | 2 | HP:0002700 | |
| HumanPheno | Abnormality of the ureter | 4.44e-04 | 383 | 26 | 8 | HP:0000069 | |
| HumanPheno | Deviated nasal septum | 5.18e-04 | 7 | 26 | 2 | HP:0004411 | |
| HumanPheno | Tethered cord | 5.31e-04 | 32 | 26 | 3 | HP:0002144 | |
| HumanPheno | Abnormal conus terminalis morphology | 5.82e-04 | 33 | 26 | 3 | HP:0031938 | |
| HumanPheno | Abnormal heart valve physiology | 6.26e-04 | 403 | 26 | 8 | HP:0031653 | |
| HumanPheno | Short phalanx of finger | 6.42e-04 | 306 | 26 | 7 | HP:0009803 | |
| HumanPheno | Abnormal scrotum morphology | 6.64e-04 | 143 | 26 | 5 | HP:0000045 | |
| HumanPheno | Abnormal number of permanent teeth | 6.93e-04 | 35 | 26 | 3 | HP:0011044 | |
| HumanPheno | Hypoplastic toenails | 7.12e-04 | 82 | 26 | 4 | HP:0001800 | |
| HumanPheno | Abnormal mitral valve morphology | 7.30e-04 | 146 | 26 | 5 | HP:0031477 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 7.54e-04 | 36 | 26 | 3 | HP:0009617 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 8.25e-04 | 319 | 26 | 7 | HP:0009767 | |
| HumanPheno | Congenital posterior urethral valve | 8.82e-04 | 9 | 26 | 2 | HP:0010957 | |
| HumanPheno | Pilomatrixoma | 8.82e-04 | 9 | 26 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 8.82e-04 | 9 | 26 | 2 | HP:0002341 | |
| HumanPheno | Broad toe | 8.91e-04 | 87 | 26 | 4 | HP:0001837 | |
| HumanPheno | Short finger | 9.22e-04 | 325 | 26 | 7 | HP:0009381 | |
| HumanPheno | Poor coordination | 9.55e-04 | 39 | 26 | 3 | HP:0002370 | |
| HumanPheno | Broad thumb | 1.01e-03 | 90 | 26 | 4 | HP:0011304 | |
| HumanPheno | Abnormality of the joints of the lower limbs | 1.03e-03 | 547 | 26 | 9 | HP:0100239 | |
| HumanPheno | Brachydactyly | 1.06e-03 | 670 | 26 | 10 | HP:0001156 | |
| HumanPheno | Short digit | 1.08e-03 | 672 | 26 | 10 | HP:0011927 | |
| HumanPheno | Frontal hirsutism | 1.10e-03 | 10 | 26 | 2 | HP:0011335 | |
| HumanPheno | Convex nasal ridge | 1.24e-03 | 95 | 26 | 4 | HP:0000444 | |
| HumanPheno | Juvenile aseptic necrosis | 1.27e-03 | 43 | 26 | 3 | HP:0100323 | |
| HumanPheno | Urethrovesical occlusion | 1.34e-03 | 11 | 26 | 2 | HP:0034378 | |
| HumanPheno | Abnormal subclavian artery morphology | 1.34e-03 | 11 | 26 | 2 | HP:0031251 | |
| Domain | Znf_C2H2 | ZNF823 BNC2 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 TUT1 ZNF226 REST RNF114 ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZBTB44 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF737 ZNF30 ZNF705B PRDM14 | 8.41e-15 | 805 | 108 | 28 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF823 BNC2 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 TUT1 ZNF226 REST RNF114 ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZBTB44 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF737 ZNF30 ZNF705B PRDM14 | 9.23e-15 | 808 | 108 | 28 | SM00355 |
| Domain | zf-C2H2 | ZNF823 BNC2 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 ZNF226 REST ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZBTB44 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF737 ZNF30 ZNF705B PRDM14 | 1.58e-14 | 693 | 108 | 26 | PF00096 |
| Domain | Znf_C2H2-like | ZNF823 BNC2 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 ZNF226 REST RNF114 ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZBTB44 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF737 ZNF30 ZNF705B PRDM14 | 5.11e-14 | 796 | 108 | 27 | IPR015880 |
| Domain | - | ZNF823 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 ZNF226 REST ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZBTB44 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF737 ZNF30 ZNF705B PRDM14 | 8.44e-14 | 679 | 108 | 25 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF823 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 ZNF226 REST ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZBTB44 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF737 ZNF30 ZNF705B PRDM14 | 1.38e-13 | 694 | 108 | 25 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF823 BNC2 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 ZNF226 REST ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZBTB44 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF737 ZNF30 ZNF705B PRDM14 | 2.12e-13 | 775 | 108 | 26 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF823 BNC2 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 ZNF226 REST ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZBTB44 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF737 ZNF30 ZNF705B PRDM14 | 2.25e-13 | 777 | 108 | 26 | PS00028 |
| Domain | KRAB | ZNF823 ZNF274 ZNF473 ZNF213 ZNF226 ZNF785 ZNF705D ZNF440 ZNF404 ZNF708 ZNF605 ZNF334 ZNF425 ZNF197 ZNF737 ZNF30 ZNF705B | 2.46e-11 | 358 | 108 | 17 | PS50805 |
| Domain | KRAB | ZNF823 ZNF274 ZNF473 ZNF213 ZNF226 ZNF785 ZNF705D ZNF440 ZNF404 ZNF708 ZNF605 ZNF334 ZNF425 ZNF197 ZNF737 ZNF30 ZNF705B | 2.46e-11 | 358 | 108 | 17 | PF01352 |
| Domain | KRAB | ZNF823 ZNF274 ZNF473 ZNF213 ZNF226 ZNF785 ZNF705D ZNF440 ZNF404 ZNF708 ZNF605 ZNF334 ZNF425 ZNF197 ZNF737 ZNF30 ZNF705B | 3.96e-11 | 369 | 108 | 17 | SM00349 |
| Domain | KRAB | ZNF823 ZNF274 ZNF473 ZNF213 ZNF226 ZNF785 ZNF705D ZNF440 ZNF404 ZNF708 ZNF605 ZNF334 ZNF425 ZNF197 ZNF737 ZNF30 ZNF705B | 4.13e-11 | 370 | 108 | 17 | IPR001909 |
| Domain | Peptidase_M12B_N | 9.08e-08 | 39 | 108 | 6 | IPR002870 | |
| Domain | Pep_M12B_propep | 9.08e-08 | 39 | 108 | 6 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.06e-07 | 40 | 108 | 6 | PS00427 | |
| Domain | Reprolysin | 1.06e-07 | 40 | 108 | 6 | PF01421 | |
| Domain | ADAM_MEPRO | 1.06e-07 | 40 | 108 | 6 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.06e-07 | 40 | 108 | 6 | PS50214 | |
| Domain | Peptidase_M12B | 1.06e-07 | 40 | 108 | 6 | IPR001590 | |
| Domain | Disintegrin_dom | 1.24e-07 | 41 | 108 | 6 | IPR001762 | |
| Domain | zf-C2H2_6 | ZNF823 ZNF473 PEG3 ZNF440 ZNF404 ZBTB44 ZNF605 ZNF334 ZNF425 ZNF197 ZNF737 ZNF30 | 2.73e-07 | 314 | 108 | 12 | PF13912 |
| Domain | ACR | 4.30e-07 | 27 | 108 | 5 | SM00608 | |
| Domain | ADAM_Cys-rich | 4.30e-07 | 27 | 108 | 5 | IPR006586 | |
| Domain | TSP_1 | 1.69e-06 | 63 | 108 | 6 | PF00090 | |
| Domain | TSP1 | 2.04e-06 | 65 | 108 | 6 | SM00209 | |
| Domain | TSP1_rpt | 2.04e-06 | 65 | 108 | 6 | IPR000884 | |
| Domain | TSP1 | 2.04e-06 | 65 | 108 | 6 | PS50092 | |
| Domain | MetalloPept_cat_dom | 7.42e-06 | 81 | 108 | 6 | IPR024079 | |
| Domain | - | 7.42e-06 | 81 | 108 | 6 | 3.40.390.10 | |
| Domain | - | RPH3AL NSD1 PHF6 G2E3 RNF114 USP20 MSL2 RING1 RNF2 TRIM17 RIMS2 USP33 | 1.11e-05 | 449 | 108 | 12 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | RPH3AL NSD1 PHF6 G2E3 RNF114 USP20 MSL2 RING1 RNF2 TRIM17 RIMS2 USP33 | 1.39e-05 | 459 | 108 | 12 | IPR013083 |
| Domain | SCAN | 1.78e-05 | 56 | 108 | 5 | SM00431 | |
| Domain | SCAN_BOX | 2.11e-05 | 58 | 108 | 5 | PS50804 | |
| Domain | SCAN | 2.11e-05 | 58 | 108 | 5 | PF02023 | |
| Domain | SCAN_dom | 2.11e-05 | 58 | 108 | 5 | IPR003309 | |
| Domain | ZINC_PROTEASE | 2.22e-05 | 98 | 108 | 6 | PS00142 | |
| Domain | Retrov_capsid_C | 2.30e-05 | 59 | 108 | 5 | IPR008916 | |
| Domain | Nuc_rcpt_coact_CREBbp | 3.31e-05 | 2 | 108 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 3.31e-05 | 2 | 108 | 2 | PF08214 | |
| Domain | KIX | 3.31e-05 | 2 | 108 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 3.31e-05 | 2 | 108 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 3.31e-05 | 2 | 108 | 2 | IPR031162 | |
| Domain | DUF902 | 3.31e-05 | 2 | 108 | 2 | PF06001 | |
| Domain | - | 3.31e-05 | 2 | 108 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 3.31e-05 | 2 | 108 | 2 | IPR010303 | |
| Domain | - | 3.31e-05 | 2 | 108 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 3.31e-05 | 2 | 108 | 2 | PF09030 | |
| Domain | - | 3.31e-05 | 2 | 108 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 3.31e-05 | 2 | 108 | 2 | PF02135 | |
| Domain | ZF_TAZ | 3.31e-05 | 2 | 108 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 3.31e-05 | 2 | 108 | 2 | IPR013178 | |
| Domain | KAT11 | 3.31e-05 | 2 | 108 | 2 | SM01250 | |
| Domain | Znf_TAZ | 3.31e-05 | 2 | 108 | 2 | IPR000197 | |
| Domain | KIX_dom | 3.31e-05 | 2 | 108 | 2 | IPR003101 | |
| Domain | KIX | 3.31e-05 | 2 | 108 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 3.31e-05 | 2 | 108 | 2 | PS51727 | |
| Domain | Disintegrin_CS | 9.97e-05 | 16 | 108 | 3 | IPR018358 | |
| Domain | EGF_1 | 1.17e-04 | 255 | 108 | 8 | PS00022 | |
| Domain | EGF-like_CS | 1.38e-04 | 261 | 108 | 8 | IPR013032 | |
| Domain | ADAM_CR | 1.44e-04 | 18 | 108 | 3 | PF08516 | |
| Domain | EGF_2 | 1.53e-04 | 265 | 108 | 8 | PS01186 | |
| Domain | - | 2.00e-04 | 20 | 108 | 3 | 4.10.70.10 | |
| Domain | Disintegrin | 2.32e-04 | 21 | 108 | 3 | PF00200 | |
| Domain | DISIN | 2.32e-04 | 21 | 108 | 3 | SM00050 | |
| Domain | ADAM_spacer1 | 3.06e-04 | 23 | 108 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 3.06e-04 | 23 | 108 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.48e-04 | 24 | 108 | 3 | IPR013273 | |
| Domain | C2H2_Znf_fam | 3.48e-04 | 24 | 108 | 3 | IPR027775 | |
| Domain | EGF_3 | 4.33e-04 | 235 | 108 | 7 | PS50026 | |
| Domain | DUSP | 4.89e-04 | 6 | 108 | 2 | SM00695 | |
| Domain | Nuc_rcpt_coact | 4.89e-04 | 6 | 108 | 2 | IPR009110 | |
| Domain | DUSP | 4.89e-04 | 6 | 108 | 2 | PF06337 | |
| Domain | EGF-like_dom | 6.12e-04 | 249 | 108 | 7 | IPR000742 | |
| Domain | Znf_RING | 6.13e-04 | 326 | 108 | 8 | IPR001841 | |
| Domain | - | 6.83e-04 | 7 | 108 | 2 | 3.30.2230.10 | |
| Domain | RAWUL | 6.83e-04 | 7 | 108 | 2 | IPR032443 | |
| Domain | DUSP | 6.83e-04 | 7 | 108 | 2 | PS51283 | |
| Domain | Pept_C19_DUSP | 6.83e-04 | 7 | 108 | 2 | IPR006615 | |
| Domain | RAWUL | 6.83e-04 | 7 | 108 | 2 | PF16207 | |
| Domain | LIM | 6.85e-04 | 69 | 108 | 4 | PF00412 | |
| Domain | - | 7.23e-04 | 70 | 108 | 4 | 2.10.110.10 | |
| Domain | Znf_LIM | 7.63e-04 | 71 | 108 | 4 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 7.63e-04 | 71 | 108 | 4 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 7.63e-04 | 71 | 108 | 4 | PS50023 | |
| Domain | LIM | 7.63e-04 | 71 | 108 | 4 | SM00132 | |
| Domain | Znf_FYVE_PHD | 1.64e-03 | 147 | 108 | 5 | IPR011011 | |
| Domain | SET | 1.71e-03 | 41 | 108 | 3 | PF00856 | |
| Domain | FYVE_2 | 1.76e-03 | 11 | 108 | 2 | PF02318 | |
| Domain | ZnF_UBP | 1.76e-03 | 11 | 108 | 2 | SM00290 | |
| Domain | RABBD | 2.11e-03 | 12 | 108 | 2 | PS50916 | |
| Domain | Rab_BD | 2.11e-03 | 12 | 108 | 2 | IPR010911 | |
| Domain | SET | 2.38e-03 | 46 | 108 | 3 | SM00317 | |
| Domain | Znf_UBP | 2.88e-03 | 14 | 108 | 2 | IPR001607 | |
| Domain | zf-UBP | 2.88e-03 | 14 | 108 | 2 | PF02148 | |
| Domain | ZF_UBP | 2.88e-03 | 14 | 108 | 2 | PS50271 | |
| Domain | SET_dom | 3.03e-03 | 50 | 108 | 3 | IPR001214 | |
| Domain | SET | 3.03e-03 | 50 | 108 | 3 | PS50280 | |
| Domain | Quinoprotein_ADH-like_supfam | 3.57e-03 | 53 | 108 | 3 | IPR011047 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 4.26e-03 | 17 | 108 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 4.26e-03 | 17 | 108 | 2 | PS51059 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.22e-09 | 68 | 80 | 8 | M27303 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF274 ZNF473 ZNF213 ZNF226 REST TNFRSF10A CREBBP ZNF785 ZNF705D SMYD2 ZNF440 RING1 ZNF708 PARP1 THBS1 ZNF605 RNF2 ZNF334 ZNF425 ZNF197 ZNF737 ZNF30 MGA EP300 NOTCH1 | 9.39e-08 | 1387 | 80 | 25 | M734 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.44e-06 | 143 | 80 | 8 | M27275 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.57e-06 | 39 | 80 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.57e-06 | 39 | 80 | 5 | MM15165 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.07e-06 | 111 | 80 | 7 | M27416 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 9.66e-06 | 8 | 80 | 3 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 2.81e-05 | 11 | 80 | 3 | M48021 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.28e-05 | 65 | 80 | 5 | M39682 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.51e-05 | 109 | 80 | 6 | MM15164 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | THSD7A ADAMTS1 MUC12 ADAMTS8 MUC13 CREBBP USP20 RING1 PREB PARP1 THBS1 NTNG2 RNF2 ADAMTS9 ASPH TNKS LTBP1 ALB EP300 USP33 VCPIP1 | 5.23e-05 | 1475 | 80 | 21 | M19806 |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 6.12e-05 | 14 | 80 | 3 | M27808 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27 | 7.62e-05 | 15 | 80 | 3 | M47973 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 8.43e-05 | 250 | 80 | 8 | M27554 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 9.34e-05 | 16 | 80 | 3 | M27121 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.10e-04 | 44 | 80 | 4 | M27295 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.55e-04 | 48 | 80 | 4 | M288 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.87e-04 | 20 | 80 | 3 | M27881 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 2.28e-04 | 53 | 80 | 4 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 2.63e-04 | 55 | 80 | 4 | M39351 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.01e-04 | 301 | 80 | 8 | MM15983 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.15e-04 | 5 | 80 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 3.15e-04 | 5 | 80 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 3.15e-04 | 5 | 80 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 3.15e-04 | 5 | 80 | 2 | M27228 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 3.45e-04 | 59 | 80 | 4 | M39886 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 3.70e-04 | 25 | 80 | 3 | MM15546 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.70e-04 | 25 | 80 | 3 | M27880 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.93e-04 | 61 | 80 | 4 | M39540 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES | 4.67e-04 | 27 | 80 | 3 | M47941 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.70e-04 | 6 | 80 | 2 | M22062 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 6.56e-04 | 7 | 80 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 8.71e-04 | 8 | 80 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 8.71e-04 | 8 | 80 | 2 | M48022 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 8.71e-04 | 8 | 80 | 2 | M46443 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 9.28e-04 | 34 | 80 | 3 | MM15531 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 9.28e-04 | 34 | 80 | 3 | M27826 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.12e-03 | 9 | 80 | 2 | M47451 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.19e-03 | 37 | 80 | 3 | M27797 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.20e-03 | 82 | 80 | 4 | MM15922 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF823 ZNF473 ZNF213 ZNF226 SMYD2 RING1 PARP1 ZNF605 RNF2 MGA EP300 NOTCH1 | 1.24e-03 | 768 | 80 | 12 | MM14851 |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.39e-03 | 10 | 80 | 2 | MM15535 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.39e-03 | 10 | 80 | 2 | M27945 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.44e-03 | 86 | 80 | 4 | M2642 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.49e-03 | 40 | 80 | 3 | MM15000 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.69e-03 | 11 | 80 | 2 | MM1521 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.69e-03 | 11 | 80 | 2 | M26924 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.72e-03 | 42 | 80 | 3 | M17541 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | THSD7A ADAMTS1 ADAMTS8 MUC13 USP20 RING1 PREB PARP1 THBS1 RNF2 ADAMTS9 TNKS LTBP1 ALB EP300 USP33 VCPIP1 | 1.76e-03 | 1389 | 80 | 17 | MM15307 |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.02e-03 | 12 | 80 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.02e-03 | 12 | 80 | 2 | M27765 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2 | 2.02e-03 | 12 | 80 | 2 | M47943 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.38e-03 | 47 | 80 | 3 | M7946 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.53e-03 | 48 | 80 | 3 | M611 | |
| Pubmed | VWF ZNF473 ADAMTS1 UBR4 PEG3 ZMYM2 LMO3 ADAMTS8 CREBBP ZNF785 SMYD2 ZBTB44 PARP1 THBS1 ZNF605 ZNF334 ADAMTS9 SULF1 ZNF197 TNKS FHL1 DNAJA1 EP300 USP33 VCPIP1 | 4.23e-13 | 1285 | 113 | 25 | 35914814 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NSD1 ZMYM2 KIF4A G2E3 REST MSL2 RING1 PREB ZBTB44 PARP1 RNF2 ASPH NFXL1 RACGAP1 MGA DNAJA1 EP300 VCPIP1 | 1.97e-07 | 1294 | 113 | 18 | 30804502 |
| Pubmed | NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain. | 2.43e-07 | 17 | 113 | 4 | 34637754 | |
| Pubmed | ZNF274 ZNF174 PEG3 TUT1 ZNF226 REST RNF114 CREBBP ZBBX RING1 GLI1 PXN FHL1 | 5.58e-07 | 709 | 113 | 13 | 22988430 | |
| Pubmed | Four-and-a-half LIM domain proteins inhibit transactivation by hypoxia-inducible factor 1. | 6.63e-07 | 6 | 113 | 3 | 22219185 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | UBR4 ZMYM2 KIF4A CREBBP SMYD2 SALL1 RNF2 GLI1 NFXL1 ALB FHL1 MGA EP300 NOTCH1 | 7.87e-07 | 857 | 113 | 14 | 25609649 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF274 ZNF473 ZNF174 ZMYM2 LMO3 ZNF226 REST CREBBP ZNF440 PREB PARP1 GLI1 PRDM14 EP300 | 1.03e-06 | 877 | 113 | 14 | 20211142 |
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 21402785 | ||
| Pubmed | 2.77e-06 | 9 | 113 | 3 | 23095891 | ||
| Pubmed | 3.66e-06 | 371 | 113 | 9 | 15747579 | ||
| Pubmed | 4.45e-06 | 486 | 113 | 10 | 20936779 | ||
| Pubmed | 4.77e-06 | 75 | 113 | 5 | 20637190 | ||
| Pubmed | The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. | 5.41e-06 | 11 | 113 | 3 | 17468742 | |
| Pubmed | 5.42e-06 | 497 | 113 | 10 | 23414517 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 6.44e-06 | 398 | 113 | 9 | 35016035 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 8.62e-06 | 146 | 113 | 6 | 23892456 | |
| Pubmed | ZNF174 PHF6 KIF4A ZNF226 CREBBP RING1 RACGAP1 LTBP1 ALB EP300 VCPIP1 | 8.62e-06 | 645 | 113 | 11 | 25281560 | |
| Pubmed | A protein interaction network for pluripotency of embryonic stem cells. | 9.75e-06 | 41 | 113 | 4 | 17093407 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.05e-05 | 2 | 113 | 2 | 34845315 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19729597 | ||
| Pubmed | Polycomb directs timely activation of germline genes in spermatogenesis. | 1.05e-05 | 2 | 113 | 2 | 28924034 | |
| Pubmed | Macrophage-released ADAMTS1 promotes muscle stem cell activation. | 1.05e-05 | 2 | 113 | 2 | 28939843 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 39287984 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20717166 | ||
| Pubmed | Nonleukemic T/B mixed phenotype acute leukemia with PHF6 and NOTCH1 mutations. | 1.05e-05 | 2 | 113 | 2 | 34473233 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25893291 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 11559821 | ||
| Pubmed | Paxillin regulates pulmonary arterial smooth muscle cell function in pulmonary hypertension. | 1.05e-05 | 2 | 113 | 2 | 22959909 | |
| Pubmed | ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. | 1.05e-05 | 2 | 113 | 2 | 17082774 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 32576962 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19822209 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24522976 | ||
| Pubmed | Polycomb function during oogenesis is required for mouse embryonic development. | 1.05e-05 | 2 | 113 | 2 | 22499591 | |
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 1.05e-05 | 2 | 113 | 2 | 21847097 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 1.05e-05 | 2 | 113 | 2 | 34813504 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21937160 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10438512 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20301699 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24639469 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 37816914 | ||
| Pubmed | Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice. | 1.05e-05 | 2 | 113 | 2 | 14981081 | |
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 1.05e-05 | 2 | 113 | 2 | 11438528 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10918613 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 35502657 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 31898871 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 37864465 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 1.05e-05 | 2 | 113 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 1.05e-05 | 2 | 113 | 2 | 27881443 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19272189 | ||
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 1.05e-05 | 2 | 113 | 2 | 32690000 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30953353 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21803292 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9811832 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24089570 | ||
| Pubmed | Thrombospondin 1 requires von Willebrand factor to modulate arterial thrombosis in mice. | 1.05e-05 | 2 | 113 | 2 | 25343959 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15706485 | ||
| Pubmed | The role of ADAMTS genes in the end stage of hip osteoarthritis. | 1.05e-05 | 2 | 113 | 2 | 30655094 | |
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 1.05e-05 | 2 | 113 | 2 | 39266679 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22303793 | ||
| Pubmed | Deubiquitinases USP20/33 promote the biogenesis of tail-anchored membrane proteins. | 1.05e-05 | 2 | 113 | 2 | 33792613 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 1.05e-05 | 2 | 113 | 2 | 34019788 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21518247 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15860545 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 1.05e-05 | 2 | 113 | 2 | 24551300 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 33911074 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9018065 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24648406 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30135524 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 18855616 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 1.05e-05 | 2 | 113 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 1.05e-05 | 2 | 113 | 2 | 29217654 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24235014 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10049825 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 18037880 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 1.05e-05 | 2 | 113 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 1.05e-05 | 2 | 113 | 2 | 29170789 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 1.05e-05 | 2 | 113 | 2 | 12646247 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 11867645 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21618342 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30446843 | ||
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 1.05e-05 | 2 | 113 | 2 | 11963968 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22053194 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 1.05e-05 | 2 | 113 | 2 | 12696060 | |
| Pubmed | ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors. | 1.05e-05 | 2 | 113 | 2 | 20546609 | |
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 1.05e-05 | 2 | 113 | 2 | 36109165 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12242694 | ||
| Pubmed | Loss- and gain-of-function mutations show a polycomb group function for Ring1A in mice. | 1.05e-05 | 2 | 113 | 2 | 11060235 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 31182547 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30635043 | ||
| Pubmed | Four and a half LIM protein 1: a partner for KCNA5 in human atrium. | 1.05e-05 | 2 | 113 | 2 | 18281375 | |
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 1.05e-05 | 2 | 113 | 2 | 27648933 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 1.05e-05 | 2 | 113 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 1.05e-05 | 2 | 113 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 1.05e-05 | 2 | 113 | 2 | 15641773 | |
| Interaction | ERG interactions | 3.73e-06 | 223 | 110 | 9 | int:ERG | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF823 BNC2 ZNF274 ZNF473 ZNF174 PEG3 ZNF213 ZNF226 ZNF785 ZNF491 ZNF705D ZNF440 ZNF404 ZNF708 ZBTB44 ZNF605 SALL1 ZNF334 ZNF425 GLI1 ZNF197 ZNF737 ZNF30 ZNF705B PRDM14 | 4.74e-15 | 718 | 89 | 25 | 28 |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.06e-04 | 19 | 89 | 3 | 50 | |
| GeneFamily | LIM domain containing | 2.03e-04 | 59 | 89 | 4 | 1218 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.10e-04 | 27 | 89 | 3 | 47 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.11e-03 | 17 | 89 | 2 | 486 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.11e-03 | 17 | 89 | 2 | 684 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.48e-03 | 18 | 89 | 2 | 91 | |
| GeneFamily | CD molecules|Mucins | 4.73e-03 | 21 | 89 | 2 | 648 | |
| GeneFamily | Ankyrin repeat domain containing | 6.88e-03 | 242 | 89 | 5 | 403 | |
| Coexpression | NABA_MATRISOME | VWF CILP ADAMTS1 ADAM20 ADAM7 CXCL14 ADAM29 MUC12 ADAMTS8 MUC13 THBS1 NTNG2 ADAMTS9 SULF1 SLPI LTBP1 | 4.69e-06 | 1026 | 108 | 16 | M5889 |
| Coexpression | NABA_ECM_REGULATORS | 6.62e-06 | 238 | 108 | 8 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 7.48e-06 | 242 | 108 | 8 | MM17062 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 1.23e-05 | 186 | 108 | 7 | M8175 | |
| Coexpression | NABA_MATRISOME | VWF CILP ADAMTS1 ADAM20 ADAM7 CXCL14 ADAM29 ADAMTS8 MUC13 THBS1 NTNG2 ADAMTS9 SULF1 SLPI LTBP1 | 1.66e-05 | 1008 | 108 | 15 | MM17056 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | ZNF823 BNC2 THSD7A PEG3 PHF6 CXCL14 LMO3 ZBTB44 THBS1 SALL1 RNF2 LNPEP SULF1 ASPH LTBP1 VCPIP1 | 4.39e-06 | 836 | 107 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-08 | 173 | 113 | 8 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-08 | 177 | 113 | 8 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-08 | 185 | 113 | 8 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.74e-07 | 199 | 113 | 7 | 8ff0fdcbe9661b013913731ec8b53d84836ca865 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.01e-07 | 200 | 113 | 7 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 180 | 113 | 6 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 180 | 113 | 6 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.68e-06 | 180 | 113 | 6 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.35e-06 | 183 | 113 | 6 | 6b5eef96b28911c752a8b6c0975918c4572cec38 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.35e-06 | 183 | 113 | 6 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.58e-06 | 184 | 113 | 6 | 7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.82e-06 | 185 | 113 | 6 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.06e-06 | 186 | 113 | 6 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | NS-critical-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.57e-06 | 188 | 113 | 6 | 6ee2e7fa80f48e4a7f3321b0776a4f697469bc61 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-06 | 189 | 113 | 6 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.83e-06 | 189 | 113 | 6 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.38e-06 | 191 | 113 | 6 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 9.66e-06 | 192 | 113 | 6 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.95e-06 | 193 | 113 | 6 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.95e-06 | 193 | 113 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.02e-05 | 194 | 113 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 195 | 113 | 6 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|myeloid / Lineage, cell class and subclass | 1.06e-05 | 195 | 113 | 6 | 15ba9c5f6ecb6ae2c603e6b036eb92b00b46f13f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 196 | 113 | 6 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.12e-05 | 197 | 113 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-05 | 197 | 113 | 6 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 198 | 113 | 6 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 198 | 113 | 6 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 198 | 113 | 6 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 199 | 113 | 6 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.18e-05 | 199 | 113 | 6 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 199 | 113 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 199 | 113 | 6 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 200 | 113 | 6 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 200 | 113 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 113 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 113 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 113 | 6 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 200 | 113 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 113 | 6 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.18e-05 | 151 | 113 | 5 | 3b4c57bad61e17a573e6f8dc6b917fba5fd56c43 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.59e-05 | 154 | 113 | 5 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.59e-05 | 154 | 113 | 5 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.84e-05 | 162 | 113 | 5 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.55e-05 | 166 | 113 | 5 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.55e-05 | 166 | 113 | 5 | 68e6fc7c0040bbe48a93f96ecf28afffdc626845 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-05 | 170 | 113 | 5 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-05 | 170 | 113 | 5 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.33e-05 | 170 | 113 | 5 | a7184dc41f90caa753860ed0f65a18133f84bc5f | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.75e-05 | 172 | 113 | 5 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.75e-05 | 172 | 113 | 5 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 173 | 113 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 173 | 113 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 173 | 113 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.18e-05 | 174 | 113 | 5 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.40e-05 | 175 | 113 | 5 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 175 | 113 | 5 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.63e-05 | 176 | 113 | 5 | 10c1f31c27e54b70f58f0b0086ac74dee2ce4197 | |
| ToppCell | Entopeduncular-Endothelial-MURAL|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.63e-05 | 176 | 113 | 5 | b8e52bec78876562a25f0b0de502aa9372b28bd2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-05 | 177 | 113 | 5 | 86c41d262142eeaa95ea7fa6668169eb1bb2953f | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 8.87e-05 | 177 | 113 | 5 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.35e-05 | 179 | 113 | 5 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 179 | 113 | 5 | b7281160c84dd053a2981c9c76ea6cc6d2592cd5 | |
| ToppCell | COPD-Stromal-SMC|COPD / Disease state, Lineage and Cell class | 9.35e-05 | 179 | 113 | 5 | 5c705627bd13a5b2c7b0062fb3d94e4eb1589327 | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 9.35e-05 | 179 | 113 | 5 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 179 | 113 | 5 | bc93883c2094f2e5bfed79facd4994a23968d875 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 179 | 113 | 5 | 0cef6d2eab2015cac0dd340532b24bfec9707330 | |
| ToppCell | COPD-Stromal-SMC|World / Disease state, Lineage and Cell class | 9.35e-05 | 179 | 113 | 5 | b2709537ec1b46457ab85261f4cdd354e60a8b29 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 179 | 113 | 5 | bb2410b3934fcc53396b96b48e0d9843df159b89 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 179 | 113 | 5 | 065241799cea30da62cb3b6f2f1970bd1b0f4e2b | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-05 | 180 | 113 | 5 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-05 | 180 | 113 | 5 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.85e-05 | 181 | 113 | 5 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 182 | 113 | 5 | 0346f81bbb1f309f3e9d063b20547d548d09472c | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 182 | 113 | 5 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 182 | 113 | 5 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 183 | 113 | 5 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 183 | 113 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 183 | 113 | 5 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 183 | 113 | 5 | 269afec240a756eec3bbae5f30ec784281af3433 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 184 | 113 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 1.06e-04 | 184 | 113 | 5 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-04 | 184 | 113 | 5 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.06e-04 | 184 | 113 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 184 | 113 | 5 | 5cfc19ffb9f074bdf0d81c86e212a708ec141631 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 185 | 113 | 5 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 185 | 113 | 5 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 185 | 113 | 5 | de353368f4f6a7a0a66e391d586879876fbe2734 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 185 | 113 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 185 | 113 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 185 | 113 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 185 | 113 | 5 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-04 | 185 | 113 | 5 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 185 | 113 | 5 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 186 | 113 | 5 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 186 | 113 | 5 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 186 | 113 | 5 | 8ea708070166c858cd9bd871670655b0114c32a5 | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 1.15e-04 | 187 | 113 | 5 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.15e-04 | 187 | 113 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 187 | 113 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| Drug | vinylene | ZNF274 ZNF174 PEG3 NSD1 ZNF213 REST RNF114 SALL1 GLI1 TRIM17 ZNF197 EP300 | 2.30e-09 | 245 | 109 | 12 | CID000006326 |
| Drug | Curcumin | ZNF823 VWF CXCL14 NPC2 TNFRSF10A CREBBP PARP1 THBS1 SULF1 GLI1 SLPI TNKS ALB RIMS2 EP300 NOTCH1 CYTH4 | 5.91e-07 | 850 | 109 | 17 | ctd:D003474 |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; MCF7; HT_HG-U133A | 4.73e-06 | 196 | 109 | 8 | 2280_DN | |
| Drug | methyl orange | 2.95e-05 | 13 | 109 | 3 | CID000011037 | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 4.19e-05 | 194 | 109 | 7 | 5075_DN | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 4.33e-05 | 195 | 109 | 7 | 2820_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 2322_UP | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 6781_UP | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 2277_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; HL60; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 2131_DN | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 3419_UP | |
| Drug | aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 1145_UP | |
| Drug | Bromperidol [10457-90-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 7457_UP | |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; HL60; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 2960_UP | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; HL60; HT_HG-U133A | 5.08e-05 | 200 | 109 | 7 | 2534_UP | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.23e-05 | 2 | 104 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.23e-05 | 2 | 104 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 1.23e-05 | 2 | 104 | 2 | cv:C5681632 | |
| Disease | Luo-Schoch-Yamamoto syndrome (implicated_via_orthology) | 1.23e-05 | 2 | 104 | 2 | DOID:0070416 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.23e-05 | 2 | 104 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.23e-05 | 2 | 104 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.23e-05 | 2 | 104 | 2 | C4551859 | |
| Disease | urinary tract obstruction (implicated_via_orthology) | 1.23e-05 | 2 | 104 | 2 | DOID:5200 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.23e-05 | 2 | 104 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 1.23e-05 | 2 | 104 | 2 | C0035934 | |
| Disease | Adenoid Cystic Carcinoma | 2.85e-05 | 100 | 104 | 5 | C0010606 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 6.24e-05 | 22 | 104 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.45e-04 | 29 | 104 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.45e-04 | 29 | 104 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.45e-04 | 29 | 104 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 1.45e-04 | 29 | 104 | 3 | C0014518 | |
| Disease | Stevens-Johnson Syndrome | 1.61e-04 | 30 | 104 | 3 | C0038325 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.41e-04 | 157 | 104 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Stage IV Skin Melanoma | 2.55e-04 | 7 | 104 | 2 | C1321872 | |
| Disease | Malignant neoplasm of breast | VWF ADAMTS1 UBR4 MCOLN1 ZNF404 PARP1 THBS1 KCNA5 GLI1 NLRC5 EP300 NOTCH1 | 4.05e-04 | 1074 | 104 | 12 | C0006142 |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 5.30e-04 | 105 | 104 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Congenital Abnormality | 6.63e-04 | 11 | 104 | 2 | C0000768 | |
| Disease | brain measurement, neuroimaging measurement | 7.46e-04 | 550 | 104 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Small cell carcinoma of lung | 9.26e-04 | 54 | 104 | 3 | C0149925 | |
| Disease | Diffuse Large B-Cell Lymphoma | 9.77e-04 | 55 | 104 | 3 | C0079744 | |
| Disease | femoral neck bone geometry | 1.09e-03 | 14 | 104 | 2 | EFO_0004511 | |
| Disease | Alopecia, Male Pattern | 1.25e-03 | 15 | 104 | 2 | C4083212 | |
| Disease | Hepatitis | 1.25e-03 | 15 | 104 | 2 | C0019158 | |
| Disease | Androgenetic Alopecia | 1.25e-03 | 15 | 104 | 2 | C0162311 | |
| Disease | hepcidin:transferrin saturation ratio | 1.25e-03 | 15 | 104 | 2 | EFO_0007902 | |
| Disease | Female pattern alopecia (disorder) | 1.25e-03 | 15 | 104 | 2 | C0263477 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 1.28e-03 | 227 | 104 | 5 | EFO_0004346, EFO_0010736 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.32e-03 | 61 | 104 | 3 | C1961102 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.32e-03 | 61 | 104 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Diabetic Angiopathies | 1.43e-03 | 16 | 104 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 1.43e-03 | 16 | 104 | 2 | C0025945 | |
| Disease | T-Cell Lymphoma | 1.43e-03 | 16 | 104 | 2 | C0079772 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.52e-03 | 64 | 104 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Bladder Neoplasm | 1.55e-03 | 140 | 104 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.59e-03 | 141 | 104 | 4 | C0005684 | |
| Disease | heart disease (biomarker_via_orthology) | 1.62e-03 | 17 | 104 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | food allergy measurement, parental genotype effect measurement | 1.81e-03 | 18 | 104 | 2 | EFO_0005939, EFO_0007016 | |
| Disease | Pseudopelade | 2.02e-03 | 19 | 104 | 2 | C0086873 | |
| Disease | Alopecia | 2.02e-03 | 19 | 104 | 2 | C0002170 | |
| Disease | Nephritis, Tubulointerstitial | 2.47e-03 | 21 | 104 | 2 | C0041349 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.51e-03 | 160 | 104 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Renal glomerular disease | 2.97e-03 | 23 | 104 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.97e-03 | 23 | 104 | 2 | C4521256 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 2.97e-03 | 23 | 104 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | Nephritis, Interstitial | 3.23e-03 | 24 | 104 | 2 | C0027707 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.30e-03 | 84 | 104 | 3 | DOID:9119 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CREGSVIGKCCPSRK | 111 | Q6ZS92 | |
| CKFLPSGKVCRKEVN | 446 | Q9UKF5 | |
| QHTKGCKRKTNGGCP | 1766 | Q09472 | |
| KAQCKKSSCQGGLAP | 1556 | Q9P281 | |
| SRNLGKVGSKCCKHP | 451 | P02768 | |
| PGKINLRTCDQCKHG | 126 | Q6ZN30 | |
| DPCQKGTLGCAKKSR | 1671 | Q86TB3 | |
| GTVCGPEKICIRKKC | 611 | O43506 | |
| CQIKKAGSICRPAKD | 451 | Q9H2U9 | |
| DSPRKLDKCGVCGGK | 671 | Q9UP79 | |
| FVCDNCLKKTGRPRK | 1306 | Q92793 | |
| KKRASKETADCPGHG | 416 | Q6P1R4 | |
| KKCAGQHRSLGPKDS | 721 | Q8WZ64 | |
| PKEGCKIRCANETKT | 696 | Q12797 | |
| NPSCRGQKIKACKTD | 326 | Q9UIA0 | |
| RISPKDRCKSCNGRK | 186 | P31689 | |
| RPCLKCEKCGKTLTS | 26 | P50238 | |
| DAGQLVSCKKPGCPK | 2126 | Q96L73 | |
| GVSPKDRCKLICQAK | 651 | Q9UHI8 | |
| SGRASCKKCSESIPK | 16 | P09874 | |
| SPCDKFRAKGRKPCK | 51 | Q9GZU1 | |
| DGCKSGINCPIQKDK | 91 | P61916 | |
| GKSSKTKPFRCKPCQ | 151 | Q13127 | |
| GRRCESVINGCKGKP | 1301 | P46531 | |
| PRVSRQKCVCGKKVA | 336 | Q6ZNB6 | |
| PLTRKCVGASQECKK | 2181 | Q8IWI9 | |
| PKAGTKSGRKKECCA | 421 | Q96RV3 | |
| KSGRKKECCAGPEEK | 426 | Q96RV3 | |
| LCVCKPGTKGKACET | 206 | Q14766 | |
| SCLKSPCNHLRGKKN | 481 | A0A1B0GTH6 | |
| NEECKSPKKGRCSGH | 351 | Q9H706 | |
| PDTKPKGCAGCNRKI | 6 | Q8TAP4 | |
| LPRCTFTKEGCHKKN | 131 | Q9UIQ6 | |
| TGEKPHKCTFEGCRK | 296 | P08151 | |
| GLKPSCAKEVKSCKG | 96 | P22413 | |
| PQEKKGCKCGRATQN | 456 | Q9HCI7 | |
| RVDGSKCKCSRKGPK | 31 | O95715 | |
| DQKGCPRKKPFECGS | 406 | Q9GZU2 | |
| SCGSSPRRKQCKKQQ | 126 | Q86WI3 | |
| KKPGNRECNHLCKSK | 1136 | A2PYH4 | |
| ATVAKGVCGACKKPI | 351 | P49023 | |
| QKGDAPTCGICHKTK | 116 | Q9UQ26 | |
| RKAKNPIGCLADRCK | 251 | Q58A45 | |
| CAGCKNPITGKRTVS | 221 | Q13642 | |
| KNGASIGCVAPRCKR | 86 | Q7L622 | |
| RQARKSACKCPRKGP | 186 | Q8N8I6 | |
| SKPCQGERKRKLVCT | 891 | Q9P2N4 | |
| ARRGSCPLEKCNVKA | 576 | P22460 | |
| KKPGCRGLRITTDAC | 46 | Q86YW7 | |
| KGKFKEICERPNGSC | 21 | A8MXU0 | |
| RCLGKCQKNSPGARK | 31 | Q8NFT6 | |
| RRRQEGKCKQCGKGF | 256 | O75912 | |
| VKVSRKNIQGCSCKG | 1076 | O95239 | |
| RKTRTPKCKVPGCFL | 486 | Q96QF7 | |
| VRKLKKGGRCCAFSP | 1036 | Q6ZMW3 | |
| GTGRCRKSCKEIERK | 41 | Q30KQ5 | |
| LKEKVICRACGTGNP | 286 | Q9NVP4 | |
| CKICGRAFTTKGNLK | 736 | Q9NSC2 | |
| ALRSGNKECPTCRKK | 76 | Q06587 | |
| RSGNKECPTCRKKLV | 81 | Q99496 | |
| RKKVCTKCGIEASPG | 116 | Q9UNE2 | |
| TTGPDCGKCKKNFRT | 311 | Q96CW9 | |
| CKEDSGCTPGKAKRK | 126 | P51575 | |
| SPTACGGKKLLNKCA | 211 | Q15464 | |
| DKGDRKFPCSLCKRS | 426 | Q9GZV8 | |
| KAGVCPPKKSAQCLR | 31 | P03973 | |
| RCSKSCGSGVKVRSK | 1046 | Q9UPZ6 | |
| CKRKRGGAKDCLLAP | 271 | Q1XH10 | |
| VPCKNGIRKCNRSKG | 121 | P60153 | |
| KPESCVPCGKRIKFG | 296 | Q9H0H5 | |
| TVRCPSCCGAKRKAK | 196 | Q9Y2M2 | |
| VSLCCKATGKPRPDK | 326 | O75339 | |
| PSEGEVCCKKRKPGQ | 81 | Q9BTD1 | |
| RQRKGAAPAEKKCGA | 116 | Q9HCU5 | |
| IHSSEKPNRCKECGK | 141 | P17039 | |
| RIHTGEKPLKCKQCG | 196 | P17039 | |
| THTGDGPQKCKICGK | 381 | P16415 | |
| HTGEKPNACKVCGKT | 166 | Q8IYI8 | |
| EQKKGPTRQRKCGFC | 6 | Q8IWS0 | |
| GKPCEGEARETKACK | 471 | P07996 | |
| KPHKCKECGKGFIQR | 396 | O14709 | |
| HRGEKPNECKECGKT | 371 | Q9HCZ1 | |
| AKGAKPCAVSAGRSK | 226 | Q15697 | |
| NKGCSHPSVKCKKRV | 911 | P04275 | |
| KQCLIKKSGGAPECA | 376 | Q9H3R2 | |
| CLKPKKPVCGVCRSA | 56 | Q9Y508 | |
| GTSKRLKVDGQKNCC | 656 | Q9H6E5 | |
| AKKGCLARVQKLCTP | 811 | O95271 | |
| KSCERQKAKEGNGCR | 471 | Q96GC6 | |
| HSGIKPFQCDRCGKK | 421 | Q8NCP5 | |
| CVTCQDKGSRKVSGP | 456 | Q5T7W7 | |
| KCTGKDGHLNKPICI | 331 | Q96JH7 | |
| KCSRGCPRGMVKVKD | 206 | O00220 | |
| SGQKKKPVGIHVCCF | 501 | Q8TE23 | |
| CGGLVRTDKKPALCK | 176 | Q9Y2K6 | |
| IHTGVKPQKCKECGK | 516 | Q494X3 | |
| KGRRKRKGSFPCPEC | 51 | Q9Y577 | |
| KCKQCGKGFSRRSAL | 336 | Q9NYT6 | |
| TKGALNKSRCTICGK | 416 | Q9UBW7 | |
| LTHSGKKPCVSKQCG | 136 | P0CI00 | |
| KKPCVSKQCGKSLRN | 141 | P0CI00 | |
| LTHSGKKPCVSKQCG | 136 | P0CH99 | |
| KKPCVSKQCGKSLRN | 141 | P0CH99 | |
| RHTGKNPFKCKECGK | 161 | P17019 | |
| LAAEKPHSCGQCGKR | 311 | O14771 | |
| TGERPHKCKICGKAF | 266 | Q8N8L2 | |
| PDGCKQCGKAFRSAK | 326 | Q8N8L2 | |
| RHTGKNPCKFTECGK | 166 | Q6ZN08 | |
| FTRKEGLSKCGRCKQ | 56 | Q9NRG4 | |
| EKPKKSSLCRTVEGC | 1781 | Q5T4S7 | |
| CPECGKGFLQKRSLK | 696 | Q6IV72 | |
| DTSGKLRIHKCKGPS | 466 | Q8IWU6 | |
| CKLSHGKTEVGRKLP | 856 | Q9Y4E6 | |
| RSHKCGTGEKSLKCP | 91 | Q86T29 | |
| CGGLARTDKKPAICK | 216 | Q8TEY7 | |
| SSECEKPKINGKVCG | 121 | A8MT70 | |
| PCVECGKGFKRKTAL | 341 | A8K8V0 | |
| HARKKPLVCNECGKT | 696 | Q8WTR7 | |
| RHTGKKPFKCIECGK | 166 | O75373 | |
| LDGKLACVNKCTKGT | 5321 | Q9UKN1 |